Media Releases - 2008

	Ranbaxy and Orchid announce strategic business alliance To leverage respective strengths for mutually beneficial business growth
	Orchid announces the formation of its Japanese Subsidiary, Orchid Pharma Japan KK To drive foray into the growing high potential Japanese generics market
	Orchid Chemicals clarifies on market fall of its shares
	Orchid receives US FDA approval for Cefuroxime Axetil ANDA 25th ANDA approval for Orchid
	Orchid receives USFDA nod for Granisetron generic formulation First Indian company to be approved for this non-antibiotic product
	Orchid ropes in Dr Gopalan to head its Drug Discovery initiatives To head Orchid Research Labs as CSO & Director
	Orchid’s Q3 FY08 revenue up by 39% to Rs 333 crore Net profit rises by 91% to Rs 54 crore
	Orchid’s formulation facilities receive MCC (South Africa) nod Cephalosporin & Penicillin Injectable facilities approved